0001562180-15-000420.txt : 20150529
0001562180-15-000420.hdr.sgml : 20150529
20150529180844
ACCESSION NUMBER: 0001562180-15-000420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150528
FILED AS OF DATE: 20150529
DATE AS OF CHANGE: 20150529
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STARR KEVIN P
CENTRAL INDEX KEY: 0001192603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 15900776
MAIL ADDRESS:
STREET 1: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-05-28
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001192603
STARR KEVIN P
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
true
false
true
false
Stock Options (Right to buy)
73.13
2015-05-28
4
A
false
13922.00
73.13
A
2025-05-28
Common Stock
13922.00
13922.00
D
The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option shall vest in full on May 28, 2016 , subject to continued service through such date.
/s/ Laurie Burlingame, as Attorney-in-Fact for Kevin P. Starr
2015-05-29